Affimed N.V. (AFMD) Social Stream



Affimed N.V. (AFMD): $6.05

0.69 (-10.24%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add AFMD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#241 of 348

in industry

AFFIMED NV (AFMD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AFMD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 5 $15 $10 $12.2 $0.663 1740.12%
2021-11-11 5 $15 $10 $12 $0.663 1709.95%
2022-01-12 5 $15 $11 $12.4 $0.663 1770.29%
2022-02-23 6 $12 $11 $11.8 $0.663 1679.79%
2022-04-01 6 $13 $7 $11 $0.663 1559.13%
2022-04-27 6 $13 $7 $10.666 $0.663 1508.75%
2022-06-01 6 $13 $7 $10.5 $0.663 1483.71%
2022-06-02 6 $12 $7 $10.333 $0.663 1458.52%
2022-08-12 6 $12 $7 $10 $0.663 1408.3%
2022-08-18 7 $12 $7 $9.714 $0.663 1365.16%
2022-10-09 7 $12 $7 $9.333 $0.663 1307.69%
2022-10-10 7 $12 $2 $8.166 $0.663 1131.67%
2022-11-03 7 $12 $2 $8.333 $0.663 1156.86%
2022-11-16 7 $12 $2 $8.714 $0.663 1214.33%
2022-12-12 8 $11 $2 $7.25 $0.663 993.51%
2023-01-05 7 $11 $2 $6.857 $0.663 934.24%
2023-05-24 7 $8.5 $1 $6.214 $0.663 837.25%
2023-06-05 7 $8 $1 $5.714 $0.663 761.84%
2023-08-10 8 $8 $1 $5.75 $0.663 767.27%
2023-08-11 8 $7 $1 $5.25 $0.663 691.86%
2023-09-28 8 $7 $1 $4.666 $0.663 603.77%
2023-11-15 8 $7 $1 $4.5 $0.663 578.73%

The Trend in the Analyst Price Target


AFMD's average price target has moved down $4.83 over the prior 13 months.

Over the past 33 weeks, AFMD's average upside potential has been 814.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-27 7 8.5 1 6.214 0.689 801.89%
2023-06-05 7 8.0 1 5.714 0.755 656.82%
2023-08-08 8 8.0 1 5.750 0.579 893.09%
2023-08-10 8 8.0 1 5.750 0.543 958.93%
2023-08-11 8 7.0 1 5.125 0.552 828.44%

AFMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 7 0 1 0 0 8

The Trend in the Broker Recommendations


Over the past 30 months, AFMD's average broker recommendation rating improved by 0.42.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AFMD as an investment opportunity.

  • In terms of how AFFIMED NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3213.84% of that group.
  • To contextualize these metrics, consider that out of all US stocks, AFFIMED NV's average analyst price target is higher than 297.99% of them.
  • In the context of stocks in the small market cap category, AFFIMED NV's number of analysts covering the stock is greater than 2551.62% of them.
  • In the context of Pharmaceutical Products stocks, AFFIMED NV's variance in analysts' estimates is lower than -1673.34% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AFFIMED NV are SMMT, KALV, and XBIT.

What is the outlook for AFMD? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!